Idiopathic Inflammatory Myopathies
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
A completed clinical trial studying families with twins or siblings discordant for rheumatic disorders, conducted by NIEHS. The study includ…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: MTS109 in Patients With Refractory Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 clinical trial evaluating MTS109 in adults with refractory autoimmune diseases is currently recruiting. The study includes systemi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial assessing safety and immunogenicity of the live attenuated tetravalent Butantan-Dengue vaccine in autoimmune rheumati…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of BEN301 Injection in theTreatment of Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 study of BEN301 Injection for multiple autoimmune diseases is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of CC312 for Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This is an early-phase 1 study evaluating CC312 for relapsed/refractory autoimmune diseases, including systemic lupus erythematosus, idiopat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]
Phase 1 clinical trial update assessing the safety and pharmacodynamics of QH103 cell injections in relapsed/refractory antibody-mediated ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies [Phase 2]
A Phase 2 clinical trial update for Nipocalimab in participants with active idiopathic inflammatory myopathies (myositis), noting the study …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) [Phase 1, Phase 2]
This is a clinical trial update for a Phase 1/2 study of NKX019 in immune‑mediated diseases, currently recruiting to assess safety and early…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease [Phase 1]
Phase 1 trial update for Prulacabtagene Leucel (Prula-cel) in autoimmune diseases, with enrollment by invitation ongoing across indications …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis. [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD5492 in adults with systemic lupus erythem…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a targeted CD19 or CD19-BCMA CAR-T therapy for autoimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 in pediatric relapsed/refractory autoimmune diseases, including SLE and diffuse systemic sclerosi…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 [Phase 1]
Phase 1 study update for KYV-101 (CARTIMMUNE) evaluating autoimmune diseases including idiopathic inflammatory myopathies, diffuse cutaneous…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of AZD0120 in Autoimmune Diseases [Phase 1]
AZD0120 from AstraZeneca is in Phase 1 testing for autoimmune diseases, including systemic sclerosis, idiopathic inflammatory myopathies, an…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Phase 2 Study of Rapcabtagene Autoleucel in Myositis [Phase 2]
Phase 2 clinical trial update investigating Racabtagene Autoleucel for idiopathic inflammatory myopathies (myositis) is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 targeted CD19 CAR-T therapy trial for autoimmune diseases has been suspended.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) [Phase 1]
A Phase 1 trial update indicates Nanjing Legend Biotech is recruiting for LUCAR-G79D to treat relapsed/refractory systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 trial evaluating autologous CD19/BCMA dual-target CAR-T therapy for relapsed/refractory autoimmune diseases; currently recruiting at…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating QT-019C, a CD19 and BCMA-targeted CAR T-cell therapy, for relapse/refractory autoimmune diseases; recrui…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis [EARLY_Phase 1]
An EARLY_PHASE1 clinical trial is evaluating the efficacy and safety of a combination of pozelimab and cemdisiran in Sporadic Inclusion Body…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases [Phase 1]
Century Therapeutics’ CNTY-101 is being evaluated in a Phase 1 study for refractory B cell–mediated autoimmune diseases, with the trial curr…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Idiopathic Inflammatory Myopathy (IIM) [Phase 1]
Phase 1 open-label study by Xencor to evaluate safety in healthy participants and those with idiopathic inflammatory myopathy; status is NOT…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial update on the recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases; the study is active b…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory study evaluating BZE2204 CAR-T cells targeting CD19/CD22/BCMA for relapsed or refractory autoimmune diseases, cur…